DISCOVERY PARK, Sandwich, United Kingdom--(BUSINESS WIRE)--Ziarco Pharma Ltd., a biopharmaceutical company focusing on the development of novel drugs against inflammatory skin disorders, today ...
Ziarco Pharma Ltd., a biopharmaceutical company focusing on the development of novel drugs against inflammatory skin disorders, today announced that dosing has started in a Phase 2a proof of concept ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback